Pure Encapsulations NSK-SD 100 mg
As low as
$78.60
In stock
SKU
lh.PE.NS16
Nattokinase, a fibrinolytic enyzme isolated from Japanese natto, helps to maintain healthy activity of the body's natural clotting and fibrinolytic processes. In an animal study conducted by Biotechnology Research Laboratories and JCR Pharmaceuticals of Kobe, Japan, nattokinase promoted healthy blood flow. Furthermore, researchers from JCR Pharmaceuticals, Oklahoma State University and Miyazaki Medical College indicated that nattokinase supports healthy clotting function compared to placebo. In 1995, scientists at the Miyazaki Medical College and Kurashiki University in Japan demonstrated the potential for nattokinase to support blood vessel health in human subjects. This product is contraindicated for individuals with a history of bleeding tendency or with conditions associated with bleeding. Due to potential synergistic effects, concurrent use with anticoagulant and blood pressure medications should be closely supervised by a health professional.
Pure Encapsulations was founded to formulate and manufacture the highest quality line of hypo-allergenic supplements available. Since our inception, we have been the industry leader in manufacturing excellence and quality control, as well as a pioneer in the production of research-based and clinically relevant formulas. There are currently nine clinical trials in progress involving Pure Encapsulations products, including studies at Stanford University, Michigan State and the Mayo Clinic.
In 2004, Pure was acquired by Atrium Innovations Inc. Atrium Innovations Inc. is a recognized leading developer, manufacturer and marketer of science-based and professionally endorsed products for the health and nutrition industries.
In 2004, Pure was acquired by Atrium Innovations Inc. Atrium Innovations Inc. is a recognized leading developer, manufacturer and marketer of science-based and professionally endorsed products for the health and nutrition industries.
Customers also purchased these items